Greenleaf Trust’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,244
| Closed | -$218K | – | 819 |
|
|
2024
Q4 | $218K | Buy |
5,244
+1,739
| +50% | +$72.3K | ﹤0.01% | 757 |
|
|
2024
Q3 | $234K | Sell |
3,505
-1,894
| -35% | -$127K | ﹤0.01% | 746 |
|
|
2024
Q2 | $641K | Buy |
5,399
+2,146
| +66% | +$255K | 0.01% | 413 |
|
|
2024
Q1 | $347K | Buy |
3,253
+953
| +41% | +$102K | ﹤0.01% | 567 |
|
|
2023
Q4 | $229K | Sell |
2,300
-485
| -17% | -$48.2K | ﹤0.01% | 679 |
|
|
2023
Q3 | $288K | Sell |
2,785
-307
| -10% | -$31.7K | ﹤0.01% | 589 |
|
|
2023
Q2 | $376K | Sell |
3,092
-425
| -12% | -$51.6K | ﹤0.01% | 529 |
|
|
2023
Q1 | $540K | Sell |
3,517
-1,547
| -31% | -$238K | 0.01% | 428 |
|
|
2022
Q4 | $910K | Buy |
5,064
+2,251
| +80% | +$405K | 0.01% | 282 |
|
|
2022
Q3 | $333K | Sell |
2,813
-217
| -7% | -$25.7K | ﹤0.01% | 505 |
|
|
2022
Q2 | $433K | Buy |
3,030
+111
| +4% | +$15.9K | 0.01% | 448 |
|
|
2022
Q1 | $503K | Buy |
2,919
+192
| +7% | +$33.1K | 0.01% | 416 |
|
|
2021
Q4 | $693K | Sell |
2,727
-741
| -21% | -$188K | 0.01% | 331 |
|
|
2021
Q3 | $1.34M | Buy |
+3,468
| New | +$1.34M | 0.02% | 178 |
|